# OnCo record paper-nct04585035-signal-transduct-target-ther-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nct04585035-signal-transduct-target-ther-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nct04585035-signal-transduct-target-ther-2025" ;
  schema:name "Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation"@en ;
  schema:description "Published report from the trial registered as NCT04585035, in Signal transduction and targeted therapy (2025), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-nct04585035-signal-transduct-target-ther-2025/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41392-025-02274-z>, <https://pubmed.ncbi.nlm.nih.gov/40523897/>, <https://europepmc.org/article/MED/40523897>, <https://clinicaltrials.gov/study/NCT04585035> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1038/s41392-025-02274-z> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Ruan DY, Wu HX, Xu Y, et al." ;
  onco:trials <https://onco.cc/trials/nct04585035/> .